Jun 14, 2022 8:00 am EDT Acasti Pharma Announces the Issuance of Additional Patents for GTX-104 and GTX-101
May 23, 2022 4:15 pm EDT Acasti Pharma Inc. Retains Lytham Partners to Lead Strategic Investor Relations and Shareholder Communication Program
May 18, 2022 7:30 am EDT Acasti Pharma Announces Positive Results for Pharmacokinetic Bridging Study, With Intravenous GTX-104 Meeting All Endpoints
May 16, 2022 1:30 pm EDT Acasti Pharma CEO to Present at Microcap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 18th
Apr 25, 2022 8:30 am EDT Acasti Pharma to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference on April 28th
Mar 25, 2022 7:30 am EDT Acasti Pharma Appoints Healthcare Industry Leader Michael L. Derby to its Board of Directors
Mar 22, 2022 7:30 am EDT Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in Japan